CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← Mechanisms of action

UDP-glucuronosyltransferases (UGTs)

PROTEIN FAMILYHomo sapiens
Children:UGT1A4UGT2B7UGT2B17UGT2B4UGT2B10UGT2B15UGT2B28UGT1A1UGT1A6UGT1A7UGT1A8UGT1A9UGT1A10UGT2A1UGT1A3

Linked proteins

  • UDP-glucuronosyltransferase 1-9 (UGT1A9) ↗
  • UDP-glucuronosyltransferase 2B17 (UGT2B17) ↗
  • UDP-glucuronosyltransferase 2B4 (UGT2B4) ↗
  • UDP-glucuronosyltransferase 2B7 (UGT2B7) ↗
  • UDP-glucuronosyltransferase 1-6 (UGT1A6) ↗
  • UDP-glucuronosyltransferase 1-1 (UGT1A1) ↗
  • UDP-glucuronosyltransferase 1-4 (UGT1A4) ↗
  • UDP-glucuronosyltransferase 1-3 (UGT1A3) ↗
  • UDP-glucuronosyltransferase 2B10 (UGT2B10) ↗
  • UDP-glucuronosyltransferase 2B15 (UGT2B15) ↗
  • UDP-glucuronosyltransferase 2B28 (UGT2B28) ↗
  • UDP-glucuronosyltransferase 1-7 (UGT1A7) ↗
  • UDP-glucuronosyltransferase 1-10 (UGT1A10) ↗
  • UDP-glucuronosyltransferase 1-8 (UGT1A8) ↗
  • UDP-glucuronosyltransferase 2B11 (UGT2B11) ↗
  • UDP-glucuronosyltransferase 2A1 (UGT2A1) ↗
  • UDP-glucuronosyltransferase 2A2 (UGT2A2) ↗
  • UDP-glucuronosyltransferase 1A5 (UGT1A5) ↗
  • UDP-glucuronosyltransferase 2A3 (UGT2A3) ↗

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.